It has been reported by one group that polymorphisms in the IFN-gammaR may increase the likelihood of SLE development and it has been shown that these polymorphisms can lead to an alteration in receptor function, resulting in a decreased response to IFN-gamma [24], [25]. This evidence concerns the gene IFNG and systemic lupus erythematosus.